14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jan 15, 2024 Buy 0 Schiller Mark C. Common Stock
Jan 15, 2024 Buy 165 000 Schiller Mark C. Employee Stock Option (right to buy)
Jan 15, 2024 Buy 250 000 Schiller Mark C. Employee Stock Option (right to buy)
Jan 07, 2024 Buy 295 000 Belsky Marc Employee Stock Option (right to buy)
Jan 07, 2024 Buy 275 000 Mordwinkin Nicholas Michael Employee Stock Option (right to buy)
Nov 08, 2023 Buy 875 000 Kirk Christopher J. Employee Stock Option (right to buy)
Aug 15, 2023 Sell 3 500 000 Morningside Venture Investments Ltd Common Stock
Jul 24, 2023 Buy 52 000 Wallace Courtney Stock Option (Right to Buy)
Jul 24, 2023 Buy 26 000 Wallace Courtney Stock Option (Right to Buy)
Jul 24, 2023 Sell 52 000 Wallace Courtney Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Wallace Courtney Stock Option (Right to Buy)
Jul 24, 2023 Buy 185 000 Mordwinkin Nicholas Michael Employee Stock Option (right to buy)
Jul 24, 2023 Buy 100 000 Mordwinkin Nicholas Michael Employee Stock Option (right to buy)
Jul 24, 2023 Sell 185 000 Mordwinkin Nicholas Michael Employee Stock Option (right to buy)
Jul 24, 2023 Buy 52 000 Klearman Micki Stock Option (Right to Buy)
Jul 24, 2023 Buy 26 000 Klearman Micki Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Klearman Micki Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Klearman Micki Stock Option (Right to Buy)
Jul 24, 2023 Sell 52 000 Klearman Micki Stock Option (Right to Buy)
Jul 24, 2023 Buy 260 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Buy 190 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Buy 170 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Buy 125 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Buy 87 500 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Sell 170 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Sell 87 500 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Sell 125 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Sell 260 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Sell 190 000 Kirk Christopher J. Stock Option (right to buy)
Jul 24, 2023 Buy 26 000 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Buy 8 896 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Sell 8 896 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Sell 8 896 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Kauffman Michael Stock Option (Right to Buy)
Jul 24, 2023 Buy 300 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Buy 280 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Buy 220 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Buy 180 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Sell 300 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Sell 280 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Sell 180 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Sell 220 000 Henig Noreen Employee Stock Option (right to buy)
Jul 24, 2023 Buy 26 000 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Buy 17 793 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Buy 8 896 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Sell 17 793 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Sell 8 896 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Garner Elizabeth Stock Option (Right to Buy)
Jul 24, 2023 Buy 1 200 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Buy 580 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Buy 500 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Buy 200 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Buy 175 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Sell 1 200 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Sell 500 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Sell 200 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Sell 580 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Sell 175 000 Fowler John Franklin Employee Stock Option (right to buy)
Jul 24, 2023 Buy 26 000 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Buy 8 896 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Sell 8 896 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Sell 8 896 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Cooper Graham K Stock Option (Right to Buy)
Jul 24, 2023 Buy 26 000 Berger Franklin M Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Berger Franklin M Stock Option (Right to Buy)
Jul 24, 2023 Sell 26 000 Berger Franklin M Stock Option (Right to Buy)
Jul 24, 2023 Buy 220 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Buy 195 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Buy 140 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Buy 90 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Buy 60 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 220 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 60 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 60 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 90 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 140 000 Belsky Marc Employee Stock Option (right to buy)
Jul 24, 2023 Sell 195 000 Belsky Marc Employee Stock Option (right to buy)
Jul 20, 2023 Buy 48 950 Kirk Christopher J. Common Stock
Jul 20, 2023 Sell 48 950 Kirk Christopher J. Employee Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Berger Franklin M Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Cooper Graham K Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Garner Elizabeth Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Kauffman Michael Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Wallace Courtney Stock Option (right to buy)
Jun 15, 2023 Buy 35 000 Klearman Micki Stock Option (right to buy)
Feb 06, 2023 Sell 40 000 Morningside Venture Investments Ltd Common Stock
Feb 03, 2023 Sell 25 000 Morningside Venture Investments Ltd Common Stock
Feb 02, 2023 Sell 50 000 Morningside Venture Investments Ltd Common Stock
Feb 01, 2023 Sell 40 000 Morningside Venture Investments Ltd Common Stock
Jan 31, 2023 Sell 30 000 Morningside Venture Investments Ltd Common Stock
Jan 30, 2023 Sell 30 000 Morningside Venture Investments Ltd Common Stock
Jan 25, 2023 Sell 50 000 Morningside Venture Investments Ltd Common Stock
Jan 24, 2023 Sell 80 000 Morningside Venture Investments Ltd Common Stock
Jan 23, 2023 Sell 80 000 Morningside Venture Investments Ltd Common Stock
Jan 17, 2023 Sell 6 114 Morningside Venture Investments Ltd Common Stock
Jan 12, 2023 Sell 5 000 Morningside Venture Investments Ltd Common Stock
INSIDER POWER
-6.747
Last 100 transactions
Buy: 7 880 931 | Sell: 9 880 837 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -6.747.

In total, the insiders bought 7 880 931 and sold 9 880 837 KZR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Kezar Life Sciences Inc

Kezar Life Sciences Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b ... KZR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT